Skip to main content

Fate Therapeutics, Inc. (NASDAQ: FATE) Investor Securities Class Action Lawsuit 01/20/2023

  • If you purchased a significant amount of shares of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, and / or if you purchased any NASDAQ: FATE shares prior to April 2020 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 22, 2023. NASDAQ: FATE investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 24, 2023 - A consolidated complaint was filed. January 21, 2023 - An investor in shares of Fate Therapeutics, Inc. (NASDAQ: FATE) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Fate Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between April 2, ...

You must register (for free) or login to view the entire case.